Genmab A/S (GNMSF) Operating Leases (2019 - 2026)
Genmab A's (GNMSF) quarterly Operating Leases came in at $152.0 million in Q4 2025, up 5.56% YoY from $144.0 million in Q4 2024, and up 2.7% on a QoQ basis from $148.0 million in Q2 2025.
Genmab A/S (GNMSF) Operating Leases (2019 - 2026) Analysis & Trends
Genmab A (GNMSF) has 5 years of Operating Leases data on file, last reported at $152.0 million in Q4 2025.
- Quarterly Operating Leases rose 5.56% year-over-year to $152.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $152.0 million (up 5.56% YoY) and the FY2025 annual result came in at $152.0 million, up 5.56% from the prior year.
- Operating Leases improved to $152.0 million in Q4 2025, from $148.0 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $152.0 million in Q4 2025 to a low of $114.0 million in Q4 2023.
- A 3-year average of $140.2 million and a median of $144.0 million in 2024 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2024 — Operating Leases gained 26.32% — and 2025, when it rose 5.56%.
- Tracing GNMSF's Operating Leases over 3 years: stood at $114.0 million in 2023, then rose by 26.32% to $144.0 million in 2024, then rose by 5.56% to $152.0 million in 2025.
- The last three Operating Leases figures came in at $152.0 million (Q4 2025), $148.0 million (Q2 2025), and $143.0 million (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 120.00 Mn |
| Dec 31, 2025 | 152.00 Mn |
| Jun 30, 2025 | 148.00 Mn |
| Mar 31, 2025 | 143.00 Mn |
| Dec 31, 2024 | 144.00 Mn |
| Dec 31, 2023 | 114.00 Mn |
| Sep 30, 2020 | 337.00 Mn |
| Dec 31, 2019 | 181.00 Mn |
| Sep 30, 2019 | 188.61 Mn |